TOPAS THERAPEUTICS

topas-therapeutics-logo

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s natural immunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus v... ulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering. Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies. Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.

#People #Financial #Event #Website #More

TOPAS THERAPEUTICS

Social Links:

Industry:
Advanced Materials Biotechnology Chemical Chemical Engineering

Founded:
2006-01-01

Address:
Hamburg, Hamburg, Germany

Country:
Germany

Website Url:
http://www.topas-therapeutics.com

Total Employee:
51+

Status:
Active

Contact:
+49 40 302089010

Email Addresses:
info@topas-therapeutics.com

Total Funding:
58 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Current Employees Featured

klaus-martin_image

Klaus Martin
Klaus Martin Chief Executive Officer @ Topas Therapeutics
Chief Executive Officer
2020-01-01

cristina-min_image

Cristina Min
Cristina Min Chief Medical Officer @ Topas Therapeutics
Chief Medical Officer
2021-09-01

not_available_image

Timm-H. Jessen
Timm-H. Jessen Co-Founder, Board Member and Chief Executive Office @ Topas Therapeutics
Co-Founder, Board Member and Chief Executive Office

not_available_image

Johannes Pohlner
Johannes Pohlner Co-Founder and Chief Operating Officer @ Topas Therapeutics
Co-Founder and Chief Operating Officer

timothy-kneale_image

Timothy Kneale
Timothy Kneale President @ Topas Therapeutics
President

Founder


not_available_image

Johannes Pohlner

klaus-martin_image

Klaus Martin

not_available_image

Timm-H. Jessen

Investors List

evotec-inc_image

Evotec

Evotec investment in Series B - Topas Therapeutics

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series B - Topas Therapeutics

embl-ventures_image

EMBL Ventures

EMBL Ventures investment in Series B - Topas Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Topas Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series B - Topas Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series B - Topas Therapeutics

gimv_image

Gimv

Gimv investment in Series B - Topas Therapeutics

embl-ventures_image

EMBL Ventures

EMBL Ventures investment in Series B - Topas Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Topas Therapeutics

gimv_image

Gimv

Gimv investment in Series B - Topas Therapeutics

Newest Events participated

pre-filled-syringes-east-coast-2017_event_image Participated in Pre-Filled Syringes East Coast 2017 on 2017-04-26 as sponsor

pre-filled-syringes-east-coast-2017_event_image Participated in Pre-Filled Syringes East Coast 2017 on 2017-04-26 as exhibitor

Key Employee Changes

Date New article
2022-02-15 Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer

Official Site Inspections

http://www.topas-therapeutics.com

  • Host name: dd24006.kasserver.com
  • IP address: 85.13.146.149
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Topas Therapeutics"

Topas Therapeutics – Transforming the field of …

Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.comSee details»

Topas Therapeutics - Crunchbase Company Profile

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet …See details»

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive ...

Oct 19, 2020 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.com. CONTACT. CONTACT. ... he was Chief …See details»

Topas Therapeutics - Contacts, Employees, Board Members

Organization. Topas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. …See details»

Topas Therapeutics | Boehringer Ingelheim Venture Fund

Topas advances a versatile platform approach to establish immune tolerance in autoimmune and immune-mediated diseases. Topas is a clinical-stage biotech company, which develops a …See details»

Topas Therapeutics (Topas Therapeutics GmbH) - Startbase

Recent mentions of Topas Therapeutics in podcasts & videos: Jobs at Topas Therapeutics: Other Startups nearby. HR Puls. Startup 2012 Hamburg. HR Puls. Cloud based HR Software for …See details»

Topas Therapeutics Company Profile - Office Locations ... - Craft

Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as …See details»

Topas Therapeutics GmbH (TT) - Phoenix

Topas Therapeutics GmbH is a Germany-based and investor-funded biotech company located in Hamburg. Topas is utilizing its cutting-edge technology platform to develop a pipeline of novel therapies to treat autoimmune …See details»

Topas Therapeutics GmbH - VentureRadar

Topas Therapeutics is a clinical-stage biotechnology company with a mission to deliver novel, disease-modifying treatments for autoimmune and inflammatory diseases. At Topas we are …See details»

Topas Therapeutics - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»

Evotec spins off auto-immune disease company as 'Topas …

Mar 22, 2016 The new company, Topas Therapeutics GmbH ("Topas"), aims to build a unique pipeline of clinical-stage development projects to treat autoimmune diseases. The proceeds of …See details»

Topas Therapeutics GmbH - Drug pipelines, Patents, Clinical

Explore Topas Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 7 news, and 3 literature, Disease Domain:Immune System Diseases, …See details»

Topas Therapeutics (Topas Therapeutics GmbH) - Startbase

Die neusten Erwähnungen von Topas Therapeutics in Podcasts & Videos: Offene Jobs bei Topas Therapeutics: Weitere Startups in der Nähe von Topas Therapeutics. HR Puls. Startup 2012 …See details»

Topas Therapeutics - Portfolio Company Profile, Executives and …

See Topas Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Topas Therapeutics developed a unique technology for …See details»

Evotec gründet Topas Therapeutics GmbH aus – ein Unternehmen ...

Info@topas-therapeutics.com Topas Therapeutics GmbH Falkenried 88, Haus B 20251 Hamburg (Germany) Evotec gründet Topas Therapeutics GmbH aus – ein Unternehmen spezialisiert …See details»

Topas particle conjugates coupled with tolerogenic peptide …

Topas Therapeutics is focused on developing Topas particle conjugates (TPCs), an antigen coupled nanoparticle platform technology, that target liver sinusoidal endothelial cells to …See details»

Pipeline - Topas Therapeutics

Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.comSee details»

Topas Therapeutics Raises EUR 14 Million to Treat Immunological ...

Mar 22, 2016 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.com. CONTACT. CONTACT. CONTACT. HOME; …See details»

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief

Hamburg, 19 October 2020: Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction capabilities of the …See details»

Topas claims success in early test of ‘immune tolerance’ celiac …

1 day ago Hugo Fry, Topas Therapeutics CEO. May 5, 2025 03:01 AM EDT Updated 06:18 AM. R&D. Ex­clu­sive: Topas claims suc­cess in ear­ly test of 'im­mune tol­er­ance' ther­a­py for celi­ac …See details»